Inclusion of patients who overdose with dihydropyridine calcium channel blockers would potentially increase clinical utility of hyperglycemia.
Winchester
David E
DE
Holstege
Christopher
C
D002121:Calcium Channel Blockers / Q000494:pharmacology / Q000506:poisoning*; D004095:Dihydropyridines / Q000494:pharmacology / Q000506:poisoning*; D004110:Diltiazem / Q000506:poisoning*; D062787:Drug Overdose; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D006943:Hyperglycemia / Q000139:chemically induced*; D018579:Patient Selection; D014700:Verapamil / Q000506:poisoning*
D002121:Calcium Channel Blockers; D004095:Dihydropyridines; C038806:1,4-dihydropyridine; D014700:Verapamil; D004110:Diltiazem